VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
WMMCX
Price
$13.33
Change
+$0.02 (+0.15%)
Updated
Jul 31 closing price
Net Assets
203.31M
Interact to see
Advertisement

VSCIX vs WMMCX

VSCIX vs WMMCX Comparison Chart in %
View a ticker or compare two or three
VS
VSCIX vs. WMMCX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VSCIX is a Hold and WMMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. WMMCX (203M). VSCIX pays higher dividends than WMMCX: VSCIX (1.23) vs WMMCX (0.00). VSCIX was incepted earlier than WMMCX: VSCIX (29 years) vs WMMCX (25 years). WMMCX (2.28) is less costly to investors than VSCIX (0.03). VSCIX is a more actively managed with annual turnover of: 17.00 vs. WMMCX (2.00). WMMCX has a lower initial minimum investment than VSCIX: WMMCX (1000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. WMMCX (8.55). VSCIX return over 5 years is better than : 35.13 vs. WMMCX (-45.92).
VSCIXWMMCXVSCIX / WMMCX
Total Expense Ratio0.032.281%
Annual Report Gross Expense Ratio0.032.281%
Fund Existence29 years25 years-
Gain YTD14.59124.81359%
Front LoadN/AN/A-
Min. Initial Investment50000001000500,000%
Min. Initial Investment IRAN/AN/A-
Net Assets189B203M93,103%
Annual Yield % from dividends1.230.00-
Returns for 1 year22.588.55264%
Returns for 3 years43.44-22.06-197%
Returns for 5 years35.13-45.92-77%
Returns for 10 years156.07-36.40-429%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C